Methocarbamol

Generic Name
Methocarbamol
Brand Names
Robaxacet, Robaxacet-8, Robaxin, Robaxisal
Drug Type
Small Molecule
Chemical Formula
C11H15NO5
CAS Number
532-03-6
Unique Ingredient Identifier
125OD7737X
Background

Methocarbamol was developed in the early 1950s as a treatment for muscle spasticity and the associated pain. It is a guaiacol glyceryl ether.
...

Indication

Methocarbamol tablets and intramuscular injections are indicated in the United States as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions. Oral methocarbamol in America may be given up to 1500mg 4 times daily for 2-3 days.
...

Associated Conditions
Discomfort, Gout, Muscle Spasms, Myalgia, Pain, Rheumatism, Tetanus, Articular inflammation
Associated Therapies
-

A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement

First Posted Date
2022-11-03
Last Posted Date
2024-01-31
Lead Sponsor
Arthritis Innovation Corporation
Target Recruit Count
151
Registration Number
NCT05603832
Locations
🇺🇸

Woodland International Research Group, Little Rock, Arkansas, United States

🇺🇸

HD Research - Legent Orthopedic Hospital, Carrollton, Texas, United States

🇺🇸

Phoenix Clinical Research, Tamarac, Florida, United States

and more 4 locations

Methocarbamol in Ventral and Inguinal HR

First Posted Date
2022-05-24
Last Posted Date
2024-08-06
Lead Sponsor
Prisma Health-Upstate
Target Recruit Count
200
Registration Number
NCT05388929
Locations
🇺🇸

Prisma Health, Greenville, South Carolina, United States

Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure

First Posted Date
2021-10-29
Last Posted Date
2024-11-14
Lead Sponsor
Northwestern University
Target Recruit Count
126
Registration Number
NCT05100017
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

First Posted Date
2021-10-13
Last Posted Date
2024-06-18
Lead Sponsor
Mayo Clinic
Target Recruit Count
188
Registration Number
NCT05076110
Locations
🇺🇸

Mayo clinic, Rochester, Minnesota, United States

Japanese IP-TN Trial

Phase 3
Completed
Conditions
Interventions
First Posted Date
2016-07-13
Last Posted Date
2018-07-20
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
80
Registration Number
NCT02831569
Locations
🇯🇵

Shinjuku Res. Park Clinic, Tokyo, I.M., Tokyo, Shinjyuku-ku, Japan

🇯🇵

Fukuwa Clinic, Tokyo, Chuo-ku, Japan

🇯🇵

Tokyo-Eki Center-building Clinic, Tokyo, Chuo-ku, Japan

Orphenadrine and Methocarbamol for LBP

First Posted Date
2016-01-27
Last Posted Date
2018-06-26
Lead Sponsor
Montefiore Medical Center
Target Recruit Count
240
Registration Number
NCT02665286
Locations
🇺🇸

Montefiore Medical Center, Bronx, New York, United States

Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients

First Posted Date
2015-12-30
Last Posted Date
2018-07-24
Lead Sponsor
Tanta University
Target Recruit Count
200
Registration Number
NCT02642874
Locations
🇪🇬

Tanta university - faculty of medicine, Tanta, Elgharbia, Egypt

Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients

First Posted Date
2015-05-04
Last Posted Date
2020-02-05
Lead Sponsor
Medical College of Wisconsin
Target Recruit Count
153
Registration Number
NCT02432456
Locations
🇺🇸

Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin, United States

© Copyright 2024. All Rights Reserved by MedPath